◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

USANA HEALTH SCIENCES INC

CIK: 896264 SIC: 2833
$925.26M
Revenue
$10.76M
Net Income
78.29%
Gross Margin
4.05%
Op. Margin
$41.08M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 44 quarterly reports available
Breakdown Q4 2025
(Jan 03, 2026)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $226.20M $213.67M $235.85M $249.54M $213.61M $200.22M $212.87M
Revenue Growth % (YoY) 5.9% 6.7% 10.8% nan% nan% nan% nan%
Cost of Revenue $49.41M $48.81M $50.18M $52.45M $38.55M $39.26M $40.33M
+ Gross Profit $176.79M $164.85M $185.66M $197.09M $175.06M $160.96M $172.54M
Gross Margin % 78.2% 77.2% 78.7% 79.0% 82.0% 80.4% 81.1%
Operating Expenses $172.97M $163.63M $168.95M $181.42M $166.85M $145.36M $154.70M
Selling General & Admin $78.08M $85.95M $81.91M $91.44M $73.35M $61.30M $64.33M
+ Operating Income $3.82M $1.22M $16.72M $15.67M $8.21M $15.60M $17.84M
Operating Margin % 1.7% 0.6% 7.1% 6.3% 3.8% 7.8% 8.4%
Interest Expense $1.00K $662.00K $662.00K $52.00K $3.00K $73.00K $72.00K
Interest Income $495.00K $578.00K $619.00K $723.00K $2.74M $3.14M $2.76M
Other Income/Expense $-14.00K $41.00K $1.74M $756.00K $-390.00K $-86.00K $-349.00K
Income Before Tax $4.18M $1.79M $18.82M $16.74M $10.43M $18.61M $20.20M
Income Tax Expense $5.77M $8.46M $8.37M $7.45M $5.95M $8.00M $9.77M
+ Net Income $-1.77M $-6.52M $9.65M $9.40M $4.45M $10.61M $10.43M
Net Margin % -0.8% -3.1% 4.1% 3.8% 2.1% 5.3% 4.9%
Basic EPS nan -0.36 0.52 0.49 0.23 0.56 0.55
Diluted EPS nan -0.36 0.52 0.49 0.23 0.56 0.54
Basic Shares Outstanding -83K 18.3M 18.5M 19.0M -5K 19.1M 19.1M
Diluted Shares Outstanding -97K 18.3M 18.5M 19.1M -19K 19.1M 19.2M
Breakdown Q4 2025
(Jan 03, 2026)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $158.38M $145.35M $151.34M $179.61M $181.77M $364.89M $332.42M
Inventory $102.61M $90.78M $83.27M $73.56M $69.73M $63.98M $61.83M
Other Current Assets $4.85M $27.93M $27.26M $28.22M $27.68M $22.32M $24.83M
Total Current Assets $288.40M $264.06M $261.87M $281.39M $279.19M $451.19M $419.08M
Property Plant & Equipment $94.38M $96.21M $96.53M $94.25M $94.56M $98.03M $97.69M
Goodwill $137.96M $144.29M $144.23M $144.22M $144.17M $17.20M $16.84M
Intangible Assets $133.15M $138.16M $142.75M $147.16M $151.82M $29.24M $28.64M
Other Non-current Assets $61.80M $59.71M $62.72M $60.74M $58.81M $58.83M $50.99M
Total Assets $742.91M $726.59M $734.53M $746.60M $748.19M $671.31M $631.42M
Accounts Payable $17.26M $16.22M $17.90M $13.97M $11.98M $7.04M $6.65M
Accrued Liabilities $9.50M - - - - - -
Deferred Revenue $10.64M - - - - - -
Other Current Liabilities $97.30M $102.44M $103.73M $100.41M $104.64M $107.74M $97.25M
Total Current Liabilities $128.56M $118.66M $121.62M $137.38M $139.62M $114.78M $103.90M
Deferred Tax Liabilities $4.89M $4.47M $4.66M $4.80M $4.07M $4.73M $4.65M
Other Non-current Liabilities $23.19M $21.91M $22.68M $20.54M $18.16M $18.71M $10.66M
Total Liabilities $156.64M $145.04M $148.97M $162.72M $161.86M - -
Common Stock $18.00K $18.00K $18.00K $19.00K $19.00K $19.00K $19.00K
Retained Earnings $465.72M $467.50M $474.02M $477.63M $478.94M $474.49M $463.88M
Total Stockholders Equity $533.10M $528.07M $531.06M $529.76M $532.11M $533.09M $512.21M
Total Liabilities & Equity $742.91M $726.59M $734.53M $746.60M $748.19M $671.31M $631.42M
Breakdown Q4 2025
(Jan 03, 2026)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-1.77M $-6.52M $9.65M $9.40M $4.45M $37.58M $10.43M
Depreciation & Amortization $8.56M $7.92M $16.08M $8.34M $4.00M $10.54M $6.97M
Stock-based Compensation $3.75M $10.08M $6.50M $2.88M $3.61M $10.95M $7.40M
Change in Inventory $13.54M $21.14M $12.99M $4.92M $-1.68M $3.79M $4.49M
Change in Payables $1.07M $4.13M $5.81M $1.98M $1.77M $-3.04M $-3.31M
Operating Cash Flow $-3.39M $25.74M $27.70M $15.48M $5.79M $55.21M $25.67M
Capital Expenditure $2.79M $11.03M $7.83M $2.80M $1.80M $8.27M $5.87M
Investing Cash Flow $1.11M $-11.23M $-8.04M $-3.88M $-205.14M $-7.95M $-5.61M
Stock Repurchased - $27.51M $27.51M $12.30M - $9.44M $9.44M
Financing Cash Flow $13.45M $-54.06M $-53.08M $-14.47M $22.93M $-13.38M $-13.30M
Net Change in Cash $13.09M $-36.35M $-30.38M $-2.14M $-183.23M $34.49M $1.93M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $213.67M $200.22M $699.06M $640.89M
Cost of Revenue $48.81M $39.26M $151.44M $122.66M
Gross Profit $164.85M $160.96M $547.61M $518.23M
Operating Expenses $163.63M $145.36M $514.00M $460.12M
Selling General & Admin $85.95M $61.30M $259.29M $189.92M
Operating Income $1.22M $15.60M $33.61M $58.11M
Interest Expense $49.00K $49.00K $662.00K $73.00K
Interest Income $578.00K $3.14M $1.92M $8.58M
Other Income/Expense $41.00K $-86.00K $2.54M $-621.00K
Income Before Tax $1.79M $18.61M $37.35M $65.92M
Income Tax Expense $8.46M $8.00M $24.28M $28.35M
Net Income $-6.52M $10.61M $12.54M $37.58M
Basic EPS -0.36 0.56 0.67 1.97
Diluted EPS -0.36 0.56 0.67 1.96
Basic Shares Outstanding $18.29M $19.08M $18.62M $19.11M
Diluted Shares Outstanding $18.29M $19.08M $18.67M $19.18M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $145.35M $181.77M
Inventory $90.78M $69.73M
Other Current Assets $27.93M $27.68M
Total Current Assets $264.06M $279.19M
Property Plant & Equipment $96.21M $94.56M
Goodwill $144.29M $144.17M
Intangible Assets $138.16M $151.82M
Other Non-current Assets $59.71M $58.81M
Total Assets $726.59M $748.19M
Accounts Payable $16.22M $11.98M
Other Current Liabilities $102.44M $104.64M
Total Current Liabilities $118.66M $139.62M
Deferred Tax Liabilities $4.47M $4.07M
Other Non-current Liabilities $21.91M $18.16M
Total Liabilities $145.04M $161.86M
Common Stock $18.00K $19.00K
Retained Earnings $467.50M $478.94M
Total Stockholders Equity $528.07M $532.11M
Total Liabilities & Equity $726.59M $748.19M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-6.52M $10.61M $12.54M $37.58M
Depreciation & Amortization $7.92M $3.57M $24.00M $10.54M
Stock-based Compensation - - $10.08M $10.95M
Change in Inventory - - $21.14M $3.79M
Change in Payables - - $4.13M $-3.04M
Operating Cash Flow - - $25.74M $55.21M
Capital Expenditure - - $11.03M $8.27M
Investing Cash Flow - - $-11.23M $-7.95M
Stock Repurchased - - $27.51M $9.44M
Financing Cash Flow - - $-54.06M $-13.38M
Net Change in Cash - - $-36.35M $34.49M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...